Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes

被引：65

作者：

Erra, Elina O. ^{[1
,2
]}

Askling, Helena Hervius ^{[3
]}

Yoksan, Sutee ^{[4
]}

Rombo, Lars ^{[3
,5
]}

Riutta, Jukka ^{[6
]}

Vene, Sirkka ^{[7
]}

Lindquist, Lars ^{[8
]}

Vapalahti, Olli ^{[2
,9
,10
]}

Kantele, Anu ^{[1
,2
,6
]}

机构：

[1] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland

[2] Univ Helsinki, Fac Med, Haartman Inst, Helsinki, Finland

[3] Karolinska Inst, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden

[4] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand

[5] Sormland Cty Council, Clin Res Ctr, Eskilstuna, Sweden

[6] Aava Med Ctr, Travel Clin, Helsinki, Finland

[7] Swedish Inst Communicable Dis Control, Solna, Sweden

[8] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden

[9] Univ Helsinki, Cent Hosp, Div Virol & Immunol, HUSLAB, Helsinki, Finland

[10] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland

来源：

CLINICAL INFECTIOUS DISEASES | 2013年 / 56卷 / 02期

关键词：

Japanese encephalitis; vaccine; traveler; cross-reactive immunity; flavivirus; IMMUNOGENICITY; EMERGENCE; IMMUNITY; STRAINS; TITERS;

D O I：

10.1093/cid/cis883

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Current Japanese encephalitis vaccines are derived from strains of genotype III, yet heterologous genotypes are emerging in endemic areas. Inactivated vaccines given to European travelers were found to elicit protective levels of neutralizing antibodies against heterologous strains of genotypes I-IV.

引用

页码：267 / 270

页数：4

共 19 条

[1] Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine [J].

Beasley, DWC ;

Li, L ;

Suderman, MT ;

Guirakhoo, F ;

Trent, DW ;

Monath, TP ;

Shope, RE ;

Barrett, ADT .

VACCINE, 2004, 22 (27-28) :3722-3726

[2] Estimated global incidence of Japanese encephalitis: a systematic review [J].

Campbell, Grant L. ;

Hills, Susan L. ;

Fischer, Marc ;

Jacobson, Julie A. ;

Hoke, Charles H. ;

Hombach, Joachim M. ;

Marfin, Anthony A. ;

Solomon, Tom ;

Tsai, Theodore F. ;

Tsu, Vivien D. ;

Ginsburg, Amy S. .

BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2011, 89 (10) :766-774

[3] Japanese Encephalitis Virus Genotype Replacement, Taiwan, 2009-2010 [J].

Chen, Yi-Ying ;

Fan, Yi-Chin ;

Tu, Wu-Chun ;

Chang, Rey-Yi ;

Shih, Chen-Chang ;

Lu, In-Houng ;

Chien, Maw-Shien ;

Lee, Wei-Cheng ;

Chen, Ter-Hsin ;

Chang, Gwong-Jen ;

Chiou, Shyan-Song .

EMERGING INFECTIOUS DISEASES, 2011, 17 (12) :2354-2356

[4] Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2-to 5-year-olds and Naive 12-to 24-month-olds Multicenter Randomized Controlled Trial [J].

Chokephaibulkit, Kulkanya ;

Sirivichayakul, Chukiat ;

Thisyakorn, Usa ;

Sabchareon, Arunee ;

Pancharoen, Chitsanu ;

Bouckenooghe, Alain ;

Gailhardou, Sophia ;

Boaz, Mark ;

Feroldi, Emmanuel .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (12) :1111-1117

[5] Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51 [J].

Eder, Susanne ;

Dubischar-Kastner, Katrin ;

Firbas, Christa ;

Jelinek, Tomas ;

Jilma, Bernd ;

Kaltenboeck, Astrid ;

Knappik, Michael ;

Kollaritsch, Herwig ;

Kundi, Michael ;

Paulke-Korinek, Maria ;

Schuller, Elisabeth ;

Klade, Christoph S. .

VACCINE, 2011, 29 (14) :2607-2612

[6] A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines [J].

Erra, Elina O. ;

Askling, Helena Hervius ;

Rombo, Lars ;

Riutta, Jukka ;

Vene, Sirkka ;

Yoksan, Sutee ;

Lindquist, Lars ;

Pakkanen, Sari H. ;

Huhtamo, Eili ;

Vapalahti, Olli ;

Kantele, Anu .

CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) :825-834

[7] Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines -: Report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies [J].

Ferguson, Morag ;

Johnes, Suzanne ;

Li, Li ;

Heath, Alan ;

Barrett, Alan .

BIOLOGICALS, 2008, 36 (02) :111-116

[8] Boosting Japanese Encephalitis Vaccine [J].

Hatz, Christoph .

CLINICAL INFECTIOUS DISEASES, 2012, 55 (06) :835-836

[9]

Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]

[10] Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains [J].

Kurane, I ;

Takasaki, T .

VACCINE, 2000, 18 :33-35

← 1 2 →